Studies have revealed over 30 mutations in the microtubule-associated protein, tau, in AD patients; ranging from missense, deletion, and silent mutations in the coding region, and intronic mutations, influencing the alternative splicing of tau or its protein level (Clark et al., 1998; Hutton et al., 1998; Goedert, 2005). Here, MAPT is linked to Alzheimer disease.